150 related articles for article (PubMed ID: 20114066)
1. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
2. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
Lewis KJ; Irwin WJ; Akhtar S
J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
[TBL] [Abstract][Full Text] [Related]
3. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
4. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
[TBL] [Abstract][Full Text] [Related]
5. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
6. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
7. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
[TBL] [Abstract][Full Text] [Related]
8. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
Khan A; Sommer W; Fuxe K; Akhtar S
J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
[TBL] [Abstract][Full Text] [Related]
9. On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
Lucas B; Van Rompaey E; Remaut K; Sanders N; De Smedt SC; Demeester J
J Control Release; 2004 Apr; 96(1):207-19. PubMed ID: 15063042
[TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
11. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
Shi F; Hoekstra D
J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
13. [Antisense nucleic acid therapy of influenza virus].
Hatta T; Abe T; Takai K; Takaku H
Nihon Rinsho; 1997 Oct; 55(10):2765-71. PubMed ID: 9360404
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
15. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
Kanamaru T; Takagi T; Takakura Y; Hashida M
J Drug Target; 1998; 5(4):235-46. PubMed ID: 9713974
[TBL] [Abstract][Full Text] [Related]
16. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
[TBL] [Abstract][Full Text] [Related]
17. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
Fattal E; Bochot A
Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
[TBL] [Abstract][Full Text] [Related]
18. Studying the intracellular dissociation of polymer-oligonucleotide complexes by dual color fluorescence fluctuation spectroscopy and confocal imaging.
Lucas B; Remaut K; Sanders NN; Braeckmans K; De Smedt SC; Demeester J
Biochemistry; 2005 Jul; 44(29):9905-12. PubMed ID: 16026163
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes.
Ebbinghaus SW; Vigneswaran N; Miller CR; Chee-Awai RA; Mayfield CA; Curiel DT; Miller DM
Gene Ther; 1996 Apr; 3(4):287-97. PubMed ID: 8732160
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
